Cannabis Europa had its ninth edition this week, returning to the Barbican Centre for the first time since it began in 2018. It attracted over a thousand business executives, important EU policymakers, and patient advocates.
Prohibition Partners CEO Stephen Murphy gave a warm welcome to guests at the Barbican theatre, praising the location as a “beacon for creativity” in the UK and emphasising the importance of creativity in the cannabis sector. Mr. Murphy reflected on the first Cannabis Europa in 2018, noting that there were “little to no patients, companies, or regulations” throughout the EU. While it is simple to become irritated at the industry’s lack of change and pace, he suggested we must keep in mind how far it has come in this brief amount of time. Additionally, he emphasised that the sector must continue to place patients at the core of its business models and that there is still a need for patient integration across the board.
Our speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.
Join the leading voices in cannabis policy and business. We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.
Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. Over two days in London, you’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.
The European cannabis landscape is entering a high-growth phase, marked by the arrival of seasoned entrepreneurs and major institutional shifts. As Cannabis Europa London 2026 approaches, the first wave of speakers has been announced, highlighting a diverse intersection of pharmaceutical innovation, global policy, and venture capital. Martin Dickie MBE & Waterside Pharmaceuticals A major highlight […]
With dedicated sessions on M&A, investment, pricing strategy and market access, Cannabis Europa London 2026 is the room where Europe’s cannabis industry does business. There are cannabis conferences, and then there are the events where decisions actually get made. Cannabis Europa London has established itself as the latter—a curated gathering of the operators, investors, policymakers […]
Germany and Poland are tightening the rules on online prescribing. The ripple effects will reshape medical cannabis access across the continent. Telemedicine didn’t just support the growth of European medical cannabis—it turbocharged it. Online consultations and e-prescriptions lowered barriers for patients, expanded clinic reach beyond urban centres, and drove a surge in imports across the […]
Margins are thinning, valuations are shifting, and consolidation is coming. Here’s what operators and investors need to know heading into Cannabis Europa London. Europe’s cannabis industry has passed the point where market access alone constitutes a business model. The commercial landscape in 2026 is defined by price compression, evolving investor expectations and an M&A cycle […]
